Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Asset Writedowns and Impairment (2017 - 2025)

Research Frontiers' Asset Writedowns and Impairment history spans 7 years, with the latest figure at $129252.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $129252.0; the TTM value through Dec 2025 reached $130000.0, changed N/A, while the annual FY2025 figure was $154253.0, 516.99% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $129252.0 at Research Frontiers, up from -$99252.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $129252.0 in Q4 2025 and bottomed at -$99252.0 in Q3 2024.
  • The 4-year median for Asset Writedowns and Impairment is -$5000.0 (2022), against an average of $18333.3.
  • The largest annual shift saw Asset Writedowns and Impairment skyrocketed 2100.0% in 2023 before it plummeted 199.25% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at -$10000.0 in 2022, then surged by 1100.0% to $100000.0 in 2023, then crashed by 199.25% to -$99252.0 in 2024, then surged by 230.23% to $129252.0 in 2025.
  • Per Business Quant, the three most recent readings for REFR's Asset Writedowns and Impairment are $129252.0 (Q4 2025), -$99252.0 (Q3 2024), and $100000.0 (Q3 2023).